Skip to main content
In stock | Supportive Care (Antiemetic)

Netupitant

Oncology Type Both (Solid & Hematologic)
Drug Class / Mechanism NK-1 Receptor Antagonist
No Image
Description

Netupitant is classified as a NK-1 Receptor Antagonist, sourced for use within our Supportive Care (Antiemetic) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Supportive Care (Antiemetic)
Oncology Type Both (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3